Hydroxychloroquine’s Role in Pregnancy for Anti-Phospholipid Antibody Patients

Current treatments of anti-phospholipid antibody patients in pregnancy achieve moderate success, prompting the HYPATIA study—a trial investigating hydroxychloroquine’s effect on pregnancy outcomes. Listen to Karen Schreiber, rheumatologist at the Danish Hospital for Rheumatic Diseases, explaining the study in this MEDtalk from SCR23.